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Dear Editor,
ADDRESSING BARRIERS TO IMMUNISATION USING A
TAILORED APPROACH
Leask and Danchin report that 6 months after introduction of the
‘No Jab, No Pay’ Federal Legislation, which requires children to be
fully immunised to qualify for a range of tax benefits and supple-
ments, there was an increase of just 0.94% of 1-year olds who were
fully immunised in Australia.1 Although this change in immunisa-
tion coverage represents a 12% decrease in children previously miss-
ing out, it is not the panacea that closes all coverage gaps. As Leask
and Danchin claim, access barriers to health services or delayed
reporting to the Australian Immunisation Register (AIR) are likely to
be responsible for most children recorded as not up-to-date.1
In the Hunter New England Local Health District, we have
empirical evidence to support this claim. We conducted a study
utilising the World Health Organization’s 2013 Guide to Tailoring
Immunization Programmes (TIP).2 Despite achieving high cover-
age rates at the district level for 1-year olds (93.1%), our study
exposed pockets of low coverage in some SA2s that have persisted
for 4 years. In one local urban area, 1-year olds were particularly
represented; in 2016, 344 (37.8%) were not fully vaccinated; in
2015, 300 (33.0%); in 2014, 320 (35.2%) and in 2013,
408 (43.2%) (ABS 2011 Census data used to calculate rates).
Despite AIR data limitations, these numbers are alarming. No evi-
dence of vaccine objection amongst under vaccinated families was
found (Thomas et al., in preparation). One year after implementa-
tion of the ‘No Jab, No Pay’ legislation, there had been no impact
on 1-year olds, the age group most vulnerable to many vaccine
preventable diseases. Relying on district wide or even SA3 level
data can conceal areas of concern where relatively large numbers
of children are missing out on the benefits of immunisation.
Although Federal incentive-based coverage targets for States
and Territories exist, these do not hone in on individual commu-
nities that may not be benefiting from safe and effective immuni-
sation. Micro-level (SA2) data is available for all Australian local
health districts, and local health authorities are encourage to use
tools, such as TIP, to systematically identify gaps and work with
local interest groups to develop solutions most likely to be effec-
tive in communities where the ‘one size fits all’ approach has
proven ineffective. We are working with service providers and
community groups to address the barriers faced by the most dis-
advantaged members of this community that have not been
addressed by the strident policy initiative, building on existing
strengths and developing sustainable locally specific solutions.
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Dear Editor,
RIGHT VENTRICULAR MASS IN A NEONATE
An 18-day-old full-term baby boy was referred to our cardiology
clinic for evaluation of a pericardial effusion seen on fetal ultra-
sound. He was otherwise well and did not have any cardiorespi-
ratory compromise. Echocardiography revealed a large mass
involving solely the right ventricular (RV) free wall, measuring
3.5 × 1.6 cm (Fig. 1a). This did cause mild flow acceleration
through the RV outflow tract; however, there was no significant
inflow or outflow gradient. He subsequently underwent a car-
diac magnetic resonance imaging at 4 months of age, which
revealed a 5.4 × 2.6 × 1.7 cm lobulated myocardial soft tissue
mass involving the inferior free wall of the right ventricle
(Fig. 1b). The signal and enhancement characteristics of the
mass were most consistent with a cardiac fibroma. The mass did
not have arterial phase hyperenhancement or T2 hyperintensity
as would be expected of a haemangioma, and the myocardial
delayed enhancement pattern was not consistent with rhabdo-
myoma. The intramyocardial location with minimal heterogene-
ity and the lack of cystic elements were inconsistent with
teratoma. Subsequently, Holter monitoring for occult ventricular
arrhythmias was negative. He has been since seen at 12 and
18 months of age in the paediatric cardiology clinic. He con-
tinues to do well with no symptoms or signs of haemodynamic
compromise and is growing appropriately (Fig. 1d). On his last
echocardiogram at 18 months of age, the RV mass has
decreased to 2.5 × 1.4 cm (Fig. 1c).
Cardiac fibroma is the third most commonly seen primary
cardiac tumour with an estimated prevalence of ~12–16%.1,2
Cardiac fibromas have to be differentiated from other primary
cardiac tumours, such as rhabdomyoma (most common) and
teratoma (second most common), myxomas and haemangio-
mas. Cardiac fibromas have been seen in patients with
Beckwith–Wiedemann syndrome, basal cell carcinoma and Gor-
lin’s syndrome. With new imaging modalities, such as com-
puted tomography scan or magnetic resonance imaging, it is
now possible to non-invasively distinguish tumour types.3,4
Such differentiation is important as the management strategies
differ based on the tumour type. The decision to intervene
must be based on the presence of haemodynamic compromise
and weighed against the risks of the surgery. Various surgical
approaches include partial removal to relieve obstruction, use
of palliative procedures (Blalock–Taussig shunt) to augment
pulmonary blood flow and complete excision, and in some
cases transplantation is required for tumours that cannot be
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safely resected. Although fibromas rarely regress, our case
demonstrates that they can do so; thus, conservative manage-
ment may be a valid option in the absence of any haemody-
namic compromise or intractable arrhythmias.
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Dear Editor,
A RARE CAUSE OF DYSPHAGIA IN CHILDREN: PRIMARY
CRICOPHARYNGEAL ACHALASIA
Dysphagia can occur as a result of oropharyngeal and oesophageal
disorders. Failure of cricopharyngeus muscle relaxation at the
appropriate time during the swallowing process in the absence of
other motor or neurological abnormalities is defined as primary cri-
copharyngeal achalasia (PCA).1,2 PCA is rare in children and pae-
diatric patients usually present with choking, nasal reflux while
feeding, dysphagia and malnutrition.3 Treatment options for PCA
include medical or surgical dilatation of the upper oesophageal
sphincter (UES).4 Herein we report the successful treatment of a 2-
month-old patient with PCA, so as to increase awareness of this
rare entity, especially among clinicians with paediatric patients. The
rarity of PCA in paediatric patients and its successful treatment
make this case particularly interesting.
A 2-month-old female presented with vomiting, feeding intoler-
ance and nasal reflux immediately after breastfeeding since birth.
She was born full-term following an uncomplicated pregnancy;
Fig. 1 (a) Echocardiogram revealing a
mass involving right ventricular free wall,
measuring 3.5 × 1.6 cm. (b) Cardiac mag-
netic resonance imaging revealing a
5.4 × 2.6 cm mildly lobulated myocardial
soft tissue mass involving the inferior
free wall of the right ventricle. (c) Echocar-
diogram done at 18 months of age show-
ing that the right ventricular mass has
decreased to 2.5 × 1.4 cm. (d) Growth
chart showing that he continues to grow
and gain weight.
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